Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States

BACKGROUND: Benign prostatic hyperplasia (BPH) is a common disease in men that is characterized by lower urinary tract symptoms. Pharmacologic treatment with alpha blockers (ABs) and 5-alpha reductase inhibitors (5ARIs) is recommended to alleviate symptoms, prevent disease progression that can lead...

Descripción completa

Detalles Bibliográficos
Autores principales: DerSarkissian, Maral, Xiao, Yongling, Duh, Mei Sheng, Lefebvre, Patrick, Swensen, Andrine R., Bell, Christopher F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397950/
https://www.ncbi.nlm.nih.gov/pubmed/27668569
http://dx.doi.org/10.18553/jmcp.2016.22.10.1204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397950/
https://www.ncbi.nlm.nih.gov/pubmed/27668569
http://dx.doi.org/10.18553/jmcp.2016.22.10.1204

Ejemplares similares